tafenoquine has been researched along with cannabidiol in 1 studies
| Studies (tafenoquine) | Trials (tafenoquine) | Recent Studies (post-2010) (tafenoquine) | Studies (cannabidiol) | Trials (cannabidiol) | Recent Studies (post-2010) (cannabidiol) |
|---|---|---|---|---|---|
| 186 | 37 | 113 | 3,279 | 321 | 2,646 |
| Protein | Taxonomy | tafenoquine (IC50) | cannabidiol (IC50) |
|---|---|---|---|
| Cholinesterase | Equus caballus (horse) | 0.67 | |
| Heat sensitive channel TRPV3 | Rattus norvegicus (Norway rat) | 0.75 | |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | 0.45 | |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | 3.7 | |
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | 2.8 | |
| Transient receptor potential cation channel subfamily V member 4 | Rattus norvegicus (Norway rat) | 5.9 | |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussar, DA | 1 |
1 other study(ies) available for tafenoquine and cannabidiol
| Article | Year |
|---|---|
New Drugs 2019, part 3.
Topics: Aminoquinolines; Antibodies, Monoclonal, Humanized; Benzamides; Cannabidiol; Carbamates; Dibenzothiepins; Drug Approval; Humans; Morpholines; Oxazines; Pyridines; Pyridones; Thiepins; Triazines; United States; United States Food and Drug Administration | 2019 |